GlassScriptPhysician profile
Laura Velcu
NPI 1821093857
$9,502.44
in general payments reported to CMS, 2019-2025
14 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $5,275 · 2021: $1,018 · 2022: $137 · 2023: $2,365 · 2024: $140 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,802 · Food and Beverage: $889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,801.81 |
| Food and Beverage | $889.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,302.15 | 2020-2023 | |
| Davol INC. | $1,987.03 | 2023-2025 | Phasix Mesh |
| Zimmer Biomet Holdings, INC. | $844.41 | 2021 | |
| Cook Biotech Incorporated | $450.63 | 2023 | Biodesign, Oasis |
| Acell, INC. | $312.59 | 2019 | |
| Baxter Healthcare | $240.91 | 2021-2023 | |
| Organogenesis INC. | $101.44 | 2022 | |
| Kci USA, INC. | $72.73 | 2023 | Abthera Advance |
| Integra Lifesciences Corporation | $55.78 | 2021 | |
| Aroa Biosurgery Incorporated | $51.65 | 2023 | |
| Ethicon US, LLC | $28.55 | 2019-2022 | |
| Cumberland Pharmaceuticals, INC. | $24.27 | 2019 | |
| Mallinckrodt Enterprises LLC | $17.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Velcu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.